Mendoza TR, Wang XS, Cleeland CL, et al: The rapid assessment of fatigue severity in cancer patients: Use of the Brief Fatigue Inventory. Cancer 85:1186-1196, 1999.

Voltz R, Gultekin HG, Rosenfeld MR, et al: A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med 340:1788-1795, 1999.


Meyers CA, Weitzner MA, Valentine AD, et al: Methylphenidate improves cognition, mood, and function of brain tumor patients. J Clin Oncol 16:2522-2527, 1998.

van Dam FS, Schagen SB, Muller MJ, et al: Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose vs standard-dose chemotherapy. J Natl Cancer Inst 90:210-218, 1998.

Valentine AD, Meyers CA, Kling MA, et al: Mood and cognitive side effects of interferon-a therapy. Semin Oncol 25(suppl 1):39-47, 1998.

Ganz PA.: Cognitive dysfunction following adjuvant treatment of breast cancer: a new dose-limiting toxic effect? J Natl Cancer Inst.Feb 4;90(3):182-3. 1998.


Berman KF, Schmidt PJ, Rubinow DR, et al: Modulation of cognition-specific cortical activity by gonadal steroids: A positron-emission tomography study in women. Neurobiology 94:8836-8841, 1997.

Martin-Lester M: Cognitive function in dialysis patients. Anna J 24:359-365, 1997.

Meyers CA: Issues of quality of life in neuro-oncology, in Vecht Ch J (ed): Handbook of Clinical Neurology, vol 23, pt I, pp 389-409. Amsterdam, Elsevier, 1997.

Meyers CA, Kudelka AP, Conrad CA, et al: Neurotoxicity of CI-980, a novel mitotic inhibitor. Clin Cancer Res 3:419-422, 1997.

Sherer M, Meyers CA, Bergloff P: Efficacy of post acute brain injury rehabilitation for patients with primary malignant brain tumors. Cancer 80:250-257, 1997.

Sherwin BB. Estrogen effects on cognition in menopausal women. Neurology 1997; 7: 21-6.


Ahles TA, Tope DM, Frustenberg C, Hann D, Mills L. Psychological and neuropsychologic impact of autologous bone marrow transplantation. J Clin Oncol 1996; 14: 1457-62.

Cull A, Hay C, Love SB, Mackie M, Smets E, Stewart M. What do patients mean when they complain of concentration and memory problems? Br J Cancer 1996; 74: 1674-9.

Newton C, Slota D, Yuzpe AA, et al: Memory complaints associated with the use of gonadotropin-releasing hormone agonists: A preliminary study. Fertil Steril 65:1253-1255, 1996.

Olofsson SM, Weitzner MA, Valentine AD, et al: A retrospective study of the psychiatric management and outcome of delirium in the cancer patient. Support Care Cancer 4:351-357, 1996.

Oosterhout AGM, Ganzevles PGJ, Wilmink JT, de Geus BWJ, Vonderen RGMW, Twijnstra A. Sequelae in long-term survivors of small cell lung cancer. Int J Radiat Oncol Biol Phys 1996; 5: 1037-44.

Ponds RWHM, Jolles J. Memory complaints in elderly people: the role of memory abilities, metamemory, depression and personality. Educ Gerontol 1996; 22: 341-57.

Scheibel RS, Meyers CA, Levin VA: Cognitive dysfunction following surgery for intracerebral glioma: Influence of histopathology, lesion location, and treatment. J Neurooncol 30:61-69, 1996.

Sherwin BB. Hormones, mood, and cognitive functioning in postmenopausal women. Obstet Gynecol 1996; 87: 20-6.

Sherwin BB, Tulandi T: “Add-back” estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. J Clin Endocrinol Metab 81:2545-2549, 1996.


Boogerd W. Neurological complications of chemotherapy. In: Vinken and Bruyn. Handbook of clinical neurology: Intoxications of the nervous system. Part II. Elsevier Science, 1995: 527-46. 

Meyers CA, Byrne KS, Komaki R: Cognitive deficits in patients with small- cell lung cancer before and after chemotherapy. Lung Cancer 12:231-235, 1995.

Meyers CA, Valentine AD: Neurological and psychiatric adverse effects of immunological therapy. CNS Drugs 3:56-68, 1995.

Pavol MA, Meyers CA, Rexer JL, et al: Pattern of neurobehavioral deficits associated with interferon-a therapy for leukemia. Neurology 45:947-950, 1995.

Weitzner MA, Meyers CA, Valentine AD: Methylphenidate in the treatment of neurobehavioral slowing associated with cancer and cancer treatment. J Neuropsychiatry Clin Neurosci 7:347-350, 1995.

Wieneke MH, Dienst ER. Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-oncology 1995; 4: 61-6.


Cook A, Burkhardt A: The effect of cancer diagnosis and treatment on hand function. Am J Occup Ther 48:836-839, 1994.

Cull A, Gregor A, Hopwood P, Macbeth F, Karnicka-Mlodkowska H, Thacher N, et al. Neurological and cognitive impairment on long-term survivors of small cell lung cancer. Eur J Cancer 1994; 30a: 1067-74.

Ibbotson T, Maguire P, Selby P, Priestman T, Wallace L. Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer 1994; 30a: 37-40

Lynch HT, Droszcz CP, Albano WA, Lynch JF. Organic brain syndrome secondary to 5-fluorouracil toxicity. Dis Colon Rectum 1994; 24: 130-1.

Meyers CA, Weitzner M, Byrne K, et al: Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation. J Clin Oncol 12:820-826, 1994.

Olivotto JA, Bajdik CD, Math M, Plenderleith JH, Coppin CM, Gelmon KA, et al. Adjuvant systemic therapy and survival after breast cancer. N Engl J Med, 330: 805-10. 1994

Walter T: Effect of iron-deficiency anemia on cognitive skills in infancy and childhood. Bailleres Clin Haematol 7:815-827, 1994.


Friedman AJ, Juneau-Norcross M, Rein MS: Adverse effects of leuprolide acetate depot treatment. Fertil Steril 59:448-450, 1993.

Pollitt E: Iron deficiency and cognitive function. Annu Rev Nutr13:521-537, 1993.

Schweitzer VG: Ototoxicity of chemotherapeutic agents. Otolaryngol Clin North Am 26:759-789, 1993.


Andrykowski MA, Schmitt FA, Gregg ME, Brady MJ, Lamb DG, Hensley-Downey PJ. Neuropsychological impairment in adult bone marrow transplant candidates. Cancer, 70: 2288-97, 1992

Dalmau J, Graus F, Rosenblum MK, et al: Anti-Hu associated paraneoplastic encephalomyelitis/sensory neuronopathy: A clinical study of 71 patients. Medicine 71:59-72, 1992.

Meyers CA, Abbruzzese JL: Cognitive functioning in cancer patients: Effect of previous treatment. Neurology 42:434-436, 1992.

Nissenson AR: Epoetin and cognitive function. Am J Kidney Dis 20(suppl 1):21-24, 1992.


Cleeland CS: Pain assessment in cancer, in Osoba D (ed): Effect of Cancer on Quality of Life, pp 293-305. Boca Raton, Florida, CRC Press, 1991.

Gouchie C, Kimura D: The relationship between testosterone levels and cognitive ability patterns. Psychoneuroendocrinol 16:323-334, 1991.